BRIEF—Mitsubishi Tanabe continues fight against malaria

Japan’s Mitsubishi Tanabe has been awarded a grant of 192 million yen ($1.7 million) by the Global Health Innovative Technology Fund (GHIT Fund), to help develop novel antimalarial drugs.

The GHIT Fund was established in Japan in 2013 as a public-private partnership to fight infectious diseases that afflict people in the developing world, such as malaria, tuberculosis, and neglected tropical diseases (NTDs).

Mitsubishi Tanabe has contributed around 140 million yen to the fund in recent years. The company has also provided its library of 50,000 compounds for joint research with the Medicines for Malaria Venture (MMV).